BerganKDV Wealth Management’s Repligen RGEN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
$425 Sell
3
-100
-97% -$16K ﹤0.01% 826
2023
Q1
$17.3K Hold
103
﹤0.01% 533
2022
Q4
$17.4K Hold
103
﹤0.01% 509
2022
Q3
$19K Hold
103
﹤0.01% 501
2022
Q2
$17K Buy
103
+3
+3% +$474 ﹤0.01% 511
2022
Q1
$19K Hold
100
﹤0.01% 517
2021
Q4
$26K Hold
100
﹤0.01% 510
2021
Q3
$29K Hold
100
﹤0.01% 472
2021
Q2
$20K Buy
+100
New +$19.4K ﹤0.01% 520

Other funds holding RGEN

BerganKDV Wealth Management's RGEN Position: Q2 2023 in Review

BerganKDV Wealth Management reduced its Repligen (RGEN) stake by 97% in Q2 2023, selling an estimated $16K and leaving 3 shares worth $425. The position accounts for ﹤0.01% of the portfolio, ranked #826.

BerganKDV Wealth Management first reported a position in RGEN in Q2 2021 and has held it in 9 quarters since. The position peaked at $29K in Q3 2021. 447 funds tracked by Wall St. Rank hold RGEN as of Q2 2023.

  • BerganKDV Wealth Management held 3 shares of Repligen worth $425 as of Q2 2023.
  • BerganKDV Wealth Management sold 100 Repligen shares in Q2 2023, an estimated $16K.
  • Repligen made up ﹤0.01% of BerganKDV Wealth Management's portfolio in Q2 2023, its #826 holding.
  • BerganKDV Wealth Management first reported a position in Repligen in Q2 2021 and has held it in 9 quarters since.
  • BerganKDV Wealth Management's Repligen position peaked at $29K in Q3 2021.
  • 447 funds tracked by Wall St. Rank held Repligen as of Q2 2023.

Based on BerganKDV Wealth Management's 13F filing for Q2 2023, filed 24 Jul 2023.